Young Ju Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Young Ju Kim has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Sang Won Seo
Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
5 shared publications - Duk Lyul Na
Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
4 shared publications - Hee Jin Kim
Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
3 shared publications - Joon Soo Shin
Beaubrain Healthcare Co., LTD., Seoul, Korea
3 shared publications - Hyemin Jang
Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
2 shared publications - Juhee Chin
Department of Neurology, Neuroscience Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
2 shared publications
Latest Publications
- 1 September 2025
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 107 (2) , 699-709
Utility of the Seoul Cognitive Status Test to detect amyloid status in mild cognitive impairment
Background: Investigating amyloid-β (Aβ) status could offer clinical implications for the identification of and intervention for individuals at higher risk of dementia due to Alzheimer's disease (AD). The use of computerized cognitive tests has been considered valuable in detecting Aβ positivity. Objective: This study aims to examine the predictive accuracy of the Seoul Cognitive Status Test (Seoul CST) for Aβ-positive mild cognitive impairment (Aβ+ MCI). Methods: A total of 138 patients with MCI who completed the Seoul CST and underwent Aβ positron emission tomography (PET) were included in this study. Results: Participants with Aβ+ MCI performed worse in the backward task of the Visual Span Test and all memory tasks except the immediate recall of the Word Place Association Test. The composite score was developed by averaging the age-, sex-, and education-adjusted Z-scores of the tasks showing significant differences between Aβ+ and Aβ- (Aβ-negative) MCI. This composite score exhibited adequate accuracy in distinguishing between Aβ+ and Aβ- MCI (area under the curve: 0.788, 95% confidence interval: 0.703–0.872). Conclusions: The findings suggest that the Seoul CST may contribute to screening MCI patients who are likely to be Aβ+.
- 1 September 2025
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 107 (2) , 699-709
Utility of the Seoul Cognitive Status Test to detect amyloid status in mild cognitive impairment
Background: Investigating amyloid-β (Aβ) status could offer clinical implications for the identification of and intervention for individuals at higher risk of dementia due to Alzheimer's disease (AD). The use of computerized cognitive tests has been considered valuable in detecting Aβ positivity. Objective: This study aims to examine the predictive accuracy of the Seoul Cognitive Status Test (Seoul CST) for Aβ-positive mild cognitive impairment (Aβ+ MCI). Methods: A total of 138 patients with MCI who completed the Seoul CST and underwent Aβ positron emission tomography (PET) were included in this study. Results: Participants with Aβ+ MCI performed worse in the backward task of the Visual Span Test and all memory tasks except the immediate recall of the Word Place Association Test. The composite score was developed by averaging the age-, sex-, and education-adjusted Z-scores of the tasks showing significant differences between Aβ+ and Aβ- (Aβ-negative) MCI. This composite score exhibited adequate accuracy in distinguishing between Aβ+ and Aβ- MCI (area under the curve: 0.788, 95% confidence interval: 0.703–0.872). Conclusions: The findings suggest that the Seoul CST may contribute to screening MCI patients who are likely to be Aβ+.
- Open Access
- 1 January 2025
- Published by XMLink in Dementia and Neurocognitive Disorders
- Vol. 24 (4) , 286-300
Clinical Utility and Diagnostic Accuracy of the Tablet-Based Seoul Cognitive Status Test: Evidence for Scalable Cognitive Assessment
Kim YJ, et al. Dement Neurocogn Disord. 2025 Oct;24(4):286-300. https://doi.org/10.12779/dnd.2025.24.4.286
- 1 January 2025
- Published by XMLink in Dementia and Neurocognitive Disorders
- Vol. 24 (4) , 286-300
Open AccessClinical Utility and Diagnostic Accuracy of the Tablet-Based Seoul Cognitive Status Test: Evidence for Scalable Cognitive Assessment
Kim YJ, et al. Dement Neurocogn Disord. 2025 Oct;24(4):286-300. https://doi.org/10.12779/dnd.2025.24.4.286
- Open Access
- 1 January 2024
- Published by XMLink in Dementia and Neurocognitive Disorders
- Vol. 23 (4) , 224-235
Development of the Diagnostic Matrix of the Seoul Cognitive Status Test, Compared to Traditional Paper-and-Pencil Neuropsychological Tests
Na S, et al. Dement Neurocogn Disord. 2024 Oct;23(4):224-235. https://doi.org/10.12779/dnd.2024.23.4.224
- 1 January 2024
- Published by XMLink in Dementia and Neurocognitive Disorders
- Vol. 23 (4) , 224-235
Open AccessDevelopment of the Diagnostic Matrix of the Seoul Cognitive Status Test, Compared to Traditional Paper-and-Pencil Neuropsychological Tests
Na S, et al. Dement Neurocogn Disord. 2024 Oct;23(4):224-235. https://doi.org/10.12779/dnd.2024.23.4.224
- Open Access
- 1 January 2022
- Published by XMLink in Yonsei Medical Journal
- Vol. 63 (3) , 259-264
18F-THK5351 PET Positivity and Longitudinal Changes in Cognitive Function in β-Amyloid-Negative Amnestic Mild Cognitive Impairment
Chun MY, et al. Yonsei Med J. 2022 Mar;63(3):259-264. https://doi.org/10.3349/ymj.2022.63.3.259
- 1 January 2022
- Published by XMLink in Yonsei Medical Journal
- Vol. 63 (3) , 259-264
Open Access18F-THK5351 PET Positivity and Longitudinal Changes in Cognitive Function in β-Amyloid-Negative Amnestic Mild Cognitive Impairment
Chun MY, et al. Yonsei Med J. 2022 Mar;63(3):259-264. https://doi.org/10.3349/ymj.2022.63.3.259
- 31 December 2021
- Published by Wiley in European Journal of Neurology
- Vol. 29 (4) , 980-989
Longitudinal amyloid cognitive composite in preclinical Alzheimer’s disease
Background and purpose: Previous studies have developed several cognitive composites in preclinical Alzheimer disease (AD). However, more sensitive measures to track cognitive changes and therapeutic efficacy in preclinical AD are needed considering the diverse sociocultural and linguistic backgrounds. This study developed a composite score that can sensitively detect the amyloid‐β (Aβ)‐related cognitive trajectory of preclinical AD using Korean data.Methods: A total of 196 cognitively normal participants who underwent amyloid positron emission tomography were followed‐up with neuropsychological assessments. We developed the Longitudinal Amyloid Cognitive Composite in Preclinical AD (LACPA) using the linear mixed‐effects model (LMM) and z scores. The LMM was also used to investigate the longitudinal sensitivity of the LACPA and the association between time‐varying brain atrophy and the LACPA.Results: Considering the group‐time interaction effects of each subtest, the Seoul Verbal Learning Test‐Elderly version immediate recall/delayed recall/recognition, the Korean Trail Making Test B Time, and the Korean Mini‐Mental State Examination were selected as components of the LACPA. The LACPA exhibited a significant group‐time interaction effect between the Aβ+ and Aβ− groups (t = −3.288, p = 0.001). Associations between time‐varying LACPA and brain atrophy were found in the bilateral medial temporal, right lateral parietal, and right lateral frontal regions, and hippocampal volume.Conclusions: The LACPA may contribute to reduction in time and financial burden when monitoring Aβ‐related cognitive decline and therapeutic efficacy of the disease‐modifying agents specifically targeting Aβ in secondary prevention trials.
- 31 December 2021
- Published by Wiley in European Journal of Neurology
- Vol. 29 (4) , 980-989
Longitudinal amyloid cognitive composite in preclinical Alzheimer’s disease
Background and purpose: Previous studies have developed several cognitive composites in preclinical Alzheimer disease (AD). However, more sensitive measures to track cognitive changes and therapeutic efficacy in preclinical AD are needed considering the diverse sociocultural and linguistic backgrounds. This study developed a composite score that can sensitively detect the amyloid‐β (Aβ)‐related cognitive trajectory of preclinical AD using Korean data.Methods: A total of 196 cognitively normal participants who underwent amyloid positron emission tomography were followed‐up with neuropsychological assessments. We developed the Longitudinal Amyloid Cognitive Composite in Preclinical AD (LACPA) using the linear mixed‐effects model (LMM) and z scores. The LMM was also used to investigate the longitudinal sensitivity of the LACPA and the association between time‐varying brain atrophy and the LACPA.Results: Considering the group‐time interaction effects of each subtest, the Seoul Verbal Learning Test‐Elderly version immediate recall/delayed recall/recognition, the Korean Trail Making Test B Time, and the Korean Mini‐Mental State Examination were selected as components of the LACPA. The LACPA exhibited a significant group‐time interaction effect between the Aβ+ and Aβ− groups (t = −3.288, p = 0.001). Associations between time‐varying LACPA and brain atrophy were found in the bilateral medial temporal, right lateral parietal, and right lateral frontal regions, and hippocampal volume.Conclusions: The LACPA may contribute to reduction in time and financial burden when monitoring Aβ‐related cognitive decline and therapeutic efficacy of the disease‐modifying agents specifically targeting Aβ in secondary prevention trials.
- Open Access
- 1 January 2021
- Published by XMLink in Yonsei Medical Journal
- Vol. 62 (8) , 717-725
Effects of Electrical Automatic Massage on Cognition and Sleep Quality in Alzheimer's Disease Spectrum Patients: A Randomized Controlled Trial
Kim YJ, et al. Yonsei Med J. 2021 Aug;62(8):717-725. https://doi.org/10.3349/ymj.2021.62.8.717
- 1 January 2021
- Published by XMLink in Yonsei Medical Journal
- Vol. 62 (8) , 717-725
Open AccessEffects of Electrical Automatic Massage on Cognition and Sleep Quality in Alzheimer's Disease Spectrum Patients: A Randomized Controlled Trial
Kim YJ, et al. Yonsei Med J. 2021 Aug;62(8):717-725. https://doi.org/10.3349/ymj.2021.62.8.717